A clinical trial in China testing ICP-538, a treatment candidate for MS and other autoimmune diseases, has dosed its first ...
People with late-onset MS, who experience their first symptoms after age 50, tend to have faster disability progression, ...
For columnist Desiree Lama, MS Awareness Month is an opportunity for people living with MS to speak their truth about their ...
Learning acceptance is a process for guest writer. On a positive note, MS has taught her how to appreciate life more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results